PRO ARIS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 380,617 | 444,976 | 642,607 | 1,273,239 | 890,193 | 1,153,759 | 1,032,926 | 1,181,464 |
| Profit before tax | -6,390 | 3,405 | 17,220 | 38,626 | 3,713 | 6,214 | 2,367 | -4,302 |
| Net profit | -6,390 | 3,238 | 14,570 | 32,738 | 3,122 | 4,500 | 1,905 | -4,302 |
| Equity | 14,776 | 18,014 | 32,584 | 57,087 | 36,679 | 38,179 | 35,377 | 29,183 |
| Liabilities | 61,851 | 69,171 | 695,982 | 128,568 | 122,436 | 124,450 | 110,984 | 77,986 |
| Non-current assets | 11,145 | 7,349 | 4,228 | 36,015 | 28,451 | 24,889 | 19,831 | 11,906 |
| Current assets | 65,482 | 79,836 | 724,338 | 149,640 | 130,664 | 137,740 | 126,530 | 95,263 |
| Total assets | 76,627 | 87,185 | 728,566 | 185,655 | 159,115 | 162,629 | 146,361 | 107,169 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 1,681 | - |
| Social insurance contributions | - | - | - | - | - | 33,583 | 34,182 | 37,815 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -0.6% | +16.9% | +44.4% | +98.1% | -30.1% | +29.6% | -10.5% | +14.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -8.3% | 3.7% | 2.0% | 17.6% | 2.0% | 2.8% | 1.3% | -4.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -43.2% | 18.0% | 44.7% | 57.3% | 8.5% | 11.8% | 5.4% | -14.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.7% | 0.7% | 2.3% | 2.6% | 0.4% | 0.4% | 0.2% | -0.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.7% | 0.8% | 2.7% | 3.0% | 0.4% | 0.5% | 0.2% | -0.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.2 | 3.8 | 21.4 | 2.3 | 3.3 | 3.3 | 3.1 | 2.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 95,154 | 111,244 | 160,652 | 318,310 | 222,548 | 288,440 | 258,232 | 301,648 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
PRO ARIS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 288.01 |
| 2026-08-19 | 2026-08-19 | 288.01 |
| 2026-06-16 | 2026-07-08 | 0.04 |
| 2026-05-17 | 2026-06-07 | 0.04 |
PRO ARIS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
PRO ARIS, UAB (code 225955760) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €1.18M, up 14.4% year on year and 2.4% compared with 2023. Despite this revenue recovery, profitability weakened: net profit moved from €4.5K in 2023 to €1.9K in 2024 and then to a net loss of €4.3K in 2025, with the profit margin at -0.4%. The balance sheet also contracted over the period. Total assets declined from €162.6K in 2023 to €107.2K in 2025, while equity fell from €38.2K to €29.2K and liabilities decreased from €124.5K to €78.0K. Long-term assets were €11.9K and short-term assets €95.3K in 2025. Key ratios for 2025 show a return on equity of -14.7%, return on assets of -4.0%, an equity ratio of 27.2%, and debt-to-equity of 2.67. Asset turnover was 11.02x, and revenue per employee was €393.8K, while profit per employee was -€1.4K.